I'm convinced.  I'm picking up some $EVGN.

Why not just edit it and fix it?

What is "Discust?" Or is that a typo in the headline and you meant "Disgust?

Sounds like a very promising opportunity.    

 I am giving the S&P -20% at least for 2023!

Very true.  If only we all had a crystal ball to let us know when to act.

Only half these reasons are enough for me.  You did some nice research here and uncovered a very attractive opportunity!  Bullish on $SURG.

Maybe as a p4 trial they could perform a small scale fresh ERT head 2 head? I think that would be super compelling for prescribers! 
 
I also still have wondered about the once a month dosing protocol. Like every article says "may be able to do that" but what does the data say for the once monthly dosing? Was the drug effective enough? Is there NDA/EMA submissions gunning for a once a month dose protocol in labeling discussions? My guess is not as they wanna stay conservative for initial approval then work towards getting additional labelings down the road for once a month... guess time will tell but if the once a month dosing comes to fruition thats a huge advantage too. 

I'm bullish on $PLX.

Good read, thanks.

Looks like $SBEV is a good bet to weather the current stock storm.